Search for lion's mane drug interactions and you will find confident lists: blood thinners, diabetes drugs, immunosuppressants. What those lists rarely say is where each warning comes from, so we went looking for the underlying studies. The short version: no human study has tested lion's mane alongside any prescription drug. The warnings rest on test-tube and animal findings. Those are a reason for care, not evidence that an interaction happens in people.

This article is educational and is not medical advice. Do not start or stop any supplement or medication based on a web article. If you take prescription medication, talk to your prescriber or pharmacist before adding lion's mane.

The starting point: no human interaction studies

An interaction study gives people a drug with and without a supplement and measures what changes: blood levels of the drug, clotting time, blood sugar. When we searched PubMed and ClinicalTrials.gov in October 2026, we found no such study of lion's mane with any medication, completed or registered. We also found no published study showing that lion's mane changes how the liver's drug-processing enzymes (the CYP450 system behind many well-known interactions) handle medications. So when a source says lion's mane "interacts with" a drug, it is extrapolating from the lab findings below. That does not make the caution wrong. It makes it a precaution, and it should be weighed as one.

Blood thinners and antiplatelet drugs

This is the most commonly cited caution, and it traces mainly to one lab study. Mori et al. (2010) found that an ethanol extract of lion's mane strongly inhibited platelet clumping in a dish, and isolated the compound responsible, hericenone B. It blocked clumping triggered by collagen, in rabbit and in human platelets, but not clumping triggered by several other signals. This was an experiment on isolated platelets: nobody took lion's mane, and no one measured bleeding.

A second lab study gives a reassuring result on clotting itself. Poniedziałek et al. (2019) screened hot-water extracts of eight edible mushrooms, including lion's mane, against human blood. None of the extracts changed prothrombin time or INR, the clotting measures used to monitor warfarin, and the strongest antiplatelet effects in that screen came from other species.

Put together, that is a plausible lab signal on platelets, no sign of an effect on warfarin-type clotting measures, and no human data either way. If you take an anticoagulant (such as warfarin or apixaban) or an antiplatelet drug (such as clopidogrel or daily aspirin), it is reasonable to tell your prescriber before adding lion's mane, and to mention it before surgery or dental work.

Diabetes medications

The blood-sugar caution also comes from animal and lab work. In one example, rats with chemically induced diabetes given a water extract of lion's mane for 28 days had lower blood glucose and higher insulin than untreated diabetic rats (Liang et al., 2013). Lab studies have also isolated lion's mane compounds that inhibit alpha-glucosidase (Miao et al., 2026), the same enzyme that the diabetes drug acarbose targets. We found no human trial measuring lion's mane's effect on blood sugar, in people with or without diabetes.

The theoretical concern is additive: if lion's mane lowered blood sugar in people, it could add to the effect of glucose-lowering medication. Whether it does, and by how much at supplement doses, is unknown. If you take insulin or another glucose-lowering drug, tell your prescriber before starting, and keep monitoring as you normally would.

Get The Signal by email. New research, grade changes and safety notes, about every two weeks. Subscribe free

Antidepressants

The question we are asked most often has its own article. In brief: no study has tested lion's mane with SSRIs or other antidepressants, and the small mood findings behind the question do not make it a substitute for prescribed treatment.

What the small human trials touched on mood, why there are no SSRI-interaction studies, and how to think about combining them. Lion's mane and antidepressants

Lion's mane is studied in the lab for effects on immune and cancer cells (reviewed by Hetland et al., 2020), which is why some lists flag chemotherapy and immunosuppressants. Those are preclinical findings, and we found no human interaction data. One case report does show why oncology teams want to hear about every supplement. A woman with metastatic colorectal cancer had severe liver-test abnormalities at a pre-chemotherapy check, and the chemotherapy was cancelled. She had been taking capsules that combined Agaricus blazei with lion's mane powder. The authors attributed the liver injury to the Agaricus, not the lion's mane, and her liver tests improved after she stopped (Strobbe et al., 2025). Mushroom blends are common and their labels can be hard to read, so whoever manages chemotherapy or an immunosuppressant regimen needs the full product list.

Allergy is the better-documented risk

Most of the concerns above are theoretical. Allergic and hypersensitivity reactions are the risk with actual human case reports behind them. The most serious: a 63-year-old man in Japan developed acute respiratory distress syndrome, a severe lung reaction, after taking a lion's mane extract sold as a diet product. Testing showed his immune cells reacted strongly to the extract, and he recovered after steroid treatment on a ventilator (Nakatsugawa et al., 2003). It is a single case, but it is why anyone with a known mushroom allergy should avoid lion's mane, and why breathing problems or a rash mean stop and seek care.

If you take medication

  • Tell your prescriber or pharmacist, and name the product, not just "lion's mane". Extract type and dose vary widely, and blends often contain other mushrooms.
  • Start one new thing at a time, so any change is easier to attribute.
  • Mention it before surgery or dental procedures, as you would any supplement.
  • Read "no known interactions" as "not studied", not as "proven safe".

The bottom line

No human study has tested lion's mane with any medication. The common warnings trace to lab and animal findings: a platelet effect from one isolated compound, and lower blood sugar in diabetic rats. Neither has been shown in people, and the one lab test of warfarin-type clotting measures found no change. That is a reason to talk to your prescriber if you take blood thinners, diabetes medication, cancer treatment or immunosuppressants. It is not a reason to panic, and it is not proof of safety either. The best-documented risk is an allergic reaction, so a known mushroom allergy is the clearest reason to avoid it.

References

This article draws on the lab, animal and case-report research below; no human interaction studies exist to cite. See the linked studies for full methods.

  • Mori K, Kikuchi H, Obara Y, Iwashita M, Azumi Y, Kinugasa S, Inatomi S, Oshima Y, Nakahata N. "Inhibitory effect of hericenone B from Hericium erinaceus on collagen-induced platelet aggregation." Phytomedicine, 2010;17(14):1082–1085. PMID: 20637576.
  • Poniedziałek B, Siwulski M, Wiater A, et al. "The Effect of Mushroom Extracts on Human Platelet and Blood Coagulation: In vitro Screening of Eight Edible Species." Nutrients, 2019;11(12):3040. PMID: 31842490.
  • Liang B, Guo Z, Xie F, Zhao A. "Antihyperglycemic and antihyperlipidemic activities of aqueous extract of Hericium erinaceus in experimental diabetic rats." BMC Complementary and Alternative Medicine, 2013;13:253. PMID: 24090482.
  • Miao X, Kong X, Shang X, et al. "Discovery of Natural α-Glucosidase Inhibitors from Hericium erinaceus Through Integrated Isolation, Structural Characterization, In Vitro Evaluation, and Molecular Dynamics Simulations." Molecules, 2026;31(10):1605. PMID: 42197159.
  • Hetland G, Tangen JM, Mahmood F, et al. "Antitumor, Anti-Inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies." Nutrients, 2020;12(5):1339. PMID: 32397163.
  • Strobbe G, Jeanjacquot M, Potey C, Carnot A, Marliot G. "Grade 3 cytolysis in a patient with metastatic colorectal cancer consuming a mushroom powder-based alternative therapy." Journal of Oncology Pharmacy Practice, 2025;31(2):329–335. PMID: 39223928.
  • Nakatsugawa M, Takahashi H, Takezawa C, et al. "Hericium erinaceum (yamabushitake) extract-induced acute respiratory distress syndrome monitored by serum surfactant proteins." Internal Medicine, 2003;42(12):1219–1222. PMID: 14714963.